Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-044973
Filing Date
2017-12-22
Accepted
2017-12-22 14:28:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 98401
  Complete submission text file 0000000000-17-044973.txt   136314
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances